Announcements Trials
Browse Landscape

Status

Unknown 4Completed 4Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 135Observational 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Breast 1

Conditions

Lung Neoplasms 1Liver Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 85Surveys and Questionnaires 83Surgical Procedures, Operative 44Drug Therapy 32Radiotherapy 27Biopsy 26Amplified Fragment Length Polymorphism Analysis 24Neoadjuvant Therapy 23Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Data Collection 18Immunotherapy 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Magnetic Resonance Spectroscopy 16Liquid Biopsy 16pembrolizumab 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Observation 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 13Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Observational × anlotinib × Clear all
NCT06340165 2024-04-01

A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer

The First Hospital of Jilin University

Unknown
153 enrolled
Breast

Breast Neoplasms

NCT05319886 2022-05-20

AP

The First Affiliated Hospital of Xinxiang Medical College

Unknown
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04966611 2021-07-19

Anlotinib for Esophageal Cancer (AFEC)

Anyang Tumor Hospital

Unknown
200 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT04954521 2021-07-08

AFHC

People's Hospital of Guangxi Zhuang Autonomous Region

Unknown
200 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡